- Home
- REFR vs OVID Comparison
REFR vs OVID Comparison
Compare REFR & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFR
- OVID
- Stock Information
- Founded
- REFR 1965
- OVID 2014
- Country
- REFR United States
- OVID United States
- Employees
- REFR N/A
- OVID N/A
- Industry
- REFR Multi-Sector Companies
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- REFR Miscellaneous
- OVID Health Care
- Exchange
- REFR Nasdaq
- OVID Nasdaq
- Market Cap
- REFR 56.6M
- OVID 54.1M
- IPO Year
- REFR N/A
- OVID 2017
- Fundamental
- Price
- REFR $1.66
- OVID $0.74
- Analyst Decision
- REFR
- OVID Strong Buy
- Analyst Count
- REFR 0
- OVID 5
- Target Price
- REFR N/A
- OVID $4.04
- AVG Volume (30 Days)
- REFR 24.8K
- OVID 384.9K
- Earning Date
- REFR 03-06-2025
- OVID 03-07-2025
- Dividend Yield
- REFR N/A
- OVID N/A
- EPS Growth
- REFR N/A
- OVID N/A
- EPS
- REFR N/A
- OVID N/A
- Revenue
- REFR $1,469,616.00
- OVID $631,695.00
- Revenue This Year
- REFR N/A
- OVID $71.38
- Revenue Next Year
- REFR N/A
- OVID $5,144.81
- P/E Ratio
- REFR N/A
- OVID N/A
- Revenue Growth
- REFR 102.07
- OVID 113.21
- 52 Week Low
- REFR $0.93
- OVID $0.68
- 52 Week High
- REFR $2.41
- OVID $4.10
- Technical
- Relative Strength Index (RSI)
- REFR 42.72
- OVID 25.31
- Support Level
- REFR $1.62
- OVID $0.75
- Resistance Level
- REFR $1.70
- OVID $1.01
- Average True Range (ATR)
- REFR 0.10
- OVID 0.07
- MACD
- REFR 0.01
- OVID -0.02
- Stochastic Oscillator
- REFR 37.50
- OVID 6.25
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.